Anti-aging gene Klotho ameliorates diabetic nephropathy in mice by inhibiting FGF2 signaling pathway

Q L Dong1, X H Zhao1, Q Wang1

  • 1Kidney Disease and Dialysis Center, Shaanxi Provincial People's Hospital, Xi'an, China.

Insights

Klotho protein levels are reduced in diabetic nephropathy (DN) mouse kidneys. Supplementing Klotho ameliorates kidney fibrosis and may offer a targeted therapy for DN by inhibiting FGF2.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic nephropathy (DN) is a major complication of diabetes.
  • Klotho protein plays a role in kidney health, but its function in DN is not fully understood.

Purpose of the Study:

  • To investigate Klotho expression in DN mouse kidneys.
  • To explore Klotho's therapeutic effects and mechanisms in DN.

Main Methods:

  • Used three groups of mice: heterozygous db/+ , homozygous db/db, and db/db treated with Klotho.
  • Employed Western blotting and immunohistochemical staining to analyze protein expression.
  • Assessed Klotho, fibroblast growth factor 2 (FGF2), and E-cadherin levels, alongside collagen fibrosis markers.

Main Results:

  • Klotho expression was significantly lower in db/db mice compared to db/+ mice.
  • Klotho treatment reduced interstitial fibrosis and Collagen I/III content in db/db mice.
  • Overexpressed Klotho suppressed FGF2 and elevated E-cadherin in DN mouse kidneys.

Conclusions:

  • Klotho deficiency exacerbates renal injury and fibrosis in diabetic mice.
  • Klotho ameliorates DN by inhibiting FGF2 and may serve as a targeted therapeutic agent.